| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785044 | Advances in Radiation Oncology | 2016 | 22 Pages |
Abstract
SBRT is a promising option for patients with unresectable or recurrent cholangiocarcinoma either as a component of neoadjuvant therapy prior to OLT or as part of definitive therapy for patients who are unresectable and not eligible for transplantation.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kiri A. MD, Darlene MPH, Vatche G. MD, Richard S. MD, Johnny C. MD, Fady M. MD, Saeed MD, Ronald W. MD PhD, Percy MD,